Here, we performed a unique case-control study and subsequently verified the reliability of the results through meta-analysis in an effort to update the evidence of clinical application of IGF-1 in patients with depression, and to aid the field in providing a reliable basis for clinical evaluation and nursing of patients with depression. This evidence concerns the gene IGF1 and depressive symptom measurement.